Advertisement

Topics

Latest "Texas Center for Proton Therapy" News Stories

16:11 EDT 22nd April 2018 | BioPortfolio

Here are the most relevant search results for "Texas Center for Proton Therapy" found in our extensive news archives from over 250 global news sources.

More Information about Texas Center for Proton Therapy on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Texas Center for Proton Therapy for you to read. Along with our medical data and news we also list Texas Center for Proton Therapy Clinical Trials, which are updated daily. BioPortfolio also has a large database of Texas Center for Proton Therapy Companies for you to search.

Showing "Texas Center Proton Therapy" News Articles 1–25 of 13,000+

Sunday 22nd April 2018

Fallopian Tube Cancer Market Insight, Epidemiology and Market Forecast 2027 [Report Updated: 14022018] Prices from USD $6250

DelveInsight's "Fallopian Tube Cancer Market Insight, Epidemiology and Market Forecast 2027" report provides a detailed analysis of the Fallopian Tube Cancer epidemiology and market outlook for the 7MM.Markets Covered United States EU5 Germany, France, Italy, Spain, and the United Kingdom JapanStudy Period: 20162027Fallopian Tube Cancer Understanding and Treatment AlgorithmThe market report p...


Health ministry calls on people to make sure to get measles shots – Asahi Shimbun

Asahi ShimbunHealth ministry calls on people to make sure to get measles shotsAsahi ShimbunAhead of the Golden Week holiday season, the health ministry is urging the public to be fully vaccinated against the measles as an outbreak has been reported in Okinawa Prefecture and cases have spread to Nagoya. The National Institute of Infectious ...Measles outbreak in Croydon reported by Public Health En...

Saturday 21st April 2018

Houston Methodist Hospital Strategic SWOT Analysis Review [Report Updated: 21022018] Prices from USD $125

Houston Methodist Hospital Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your b...


Allergic RhinoConjunctivitis Market Insight, Epidemiology and Market Forecast 2027 [Report Updated: 14022018] Prices from USD $6250

DelveInsight's "Allergic RhinoConjunctivitis Market Insight, Epidemiology and Market Forecast 2027" report provides a detailed analysis of the Allergic RhinoConjunctivitis epidemiology and market outlook for the 7MM.Markets Covered United States EU5 Germany, France, Italy, Spain, and the United Kingdom JapanStudy Period: 20162027Allergic RhinoConjunctivitis Understanding and Treatment Algorit...

Sterol 14 AlphaDemethylase Inhibitor Pipeline Insight, 2018 [Report Updated: 14022018] Prices from USD $1250

Sterol 14 AlphaDemethylase Inhibitor Pipeline Insight, 2018 report by DelveInsight offers comprehensive insights of the pipeline under development therapeutics scenario and growth prospects across Sterol 14 AlphaDemethylase Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete p...

BioPath Holdings Inc BPTH Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27022018] Prices from USD $250

SummaryBioPath Holdings Inc BioPath is a clinical stage biotechnology company which develops targeted therapies for acute myeloid leukemia AML, chronic myeloid leukemia CML and other challenging cancers. The company's products pipeline includes prexigebersen Liposomal Grb2 Antisense and BP1002 Liposomal Bcl2. Its prexigebersen Liposomal Grb2 Antisense, is developed for the treatment of Acute Myelo...

Study shows significant benefits of nasal high flow therapy for COPD patients using Fisher & Paykel's myAirvo device

Fisher & Paykel Healthcare Corporation Limited, a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea, announced

Radiomedix Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14032018] Prices from USD $250

SummaryRadiomedix Inc Radiomedix is a biotechnology company that provides therapies. The company provides radiopharmaceuticals for diagnosis, monitoring and therapy of cancer. Its products include smartmedix system and glucomedix. Radiomedix's services include CGMP drug manufacturing suite and microPET imaging laboratory. The company has developed its own chelation technology and new imaging conju...

Progress in Migraine Research, Promius Announces Presentations for the 70th American Academy of ...

"The latest results from the MAST Study are new milestones in characterizing migraine symptoms," said Richard B. Lipton, MD, Director of Montefiore Headache Center. Read more...

Plasminogen Activator Inhibitor 1 Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1 Pipeline Review, H1 2018 [Report Updated: 06032018] Prices from USD $3500

Plasminogen Activator Inhibitor 1 Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1 Pipeline Review, H1 2018SummaryPlasminogen Activator Inhibitor 1 Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1 pipeline Target constitutes close to 9 molecules. Out of which approximately 2 molecules are developed by companies and remaining by the universities/institutes.The latest ...

Nosocomial Infections Market Insight, Epidemiology and Market Forecast 2027 [Report Updated: 14022018] Prices from USD $6250

DelveInsight's "Nosocomial Infections Market Insight, Epidemiology and Market Forecast 2027" report provides a detailed analysis of the Nosocomial Infections epidemiology and market outlook for the 7MM.Markets Covered United States EU5 Germany, France, Italy, Spain, and the United Kingdom JapanStudy Period: 20162027Nosocomial Infections Understanding and Treatment AlgorithmThe market report p...

Tocagen, ApolloBio ink pact to develop & commercialize Toca 511 & Toca FC in greater China region

Tocagen Inc., a clinical─stage, cancer─selective gene therapy company, and Beijing Apollo Venus Biomedical Technology Limited, an affiliate of ApolloBio Corp., a biopharmaceutical company focused on oncology (collectively, "ApolloBio")

British Breast Cancer Company, Endomag, Wins Queen’s Award

UK company providing more accurate tools for breast cancer removal receives prestigious business award Endomag, the surgical guidance company, today announced it has received the Queen’s Award for Enterprise in Innovation for 2018. The Award recognises the Company’s efforts in developing novel surgical tools for more accurate removal of breast canc...

Pocklington: ‘We Will Vigorously Defend Ourselves and our Nova Oculus Device from Outrageous Allegations’

Nova Oculus founder stands by innovative medical device PALM DESERT, Calif. (PRWEB) April 21, 2018 Nova Oculus Partners, LLC today issued the following statement from its founder Peter Pocklington: Egregious allegations against me, two of my associates, and our company, Nova Oculus Partners, LLC, have surfaced in recent days, most recently in the Desert Sun. These claims by the U.S. Securities a...

MVW Nutritionals® and Lutrish Partner to Expand Nutritional Options for the Cystic Fibrosis Community

Effective today, MVW Nutritionals is pleased to announce a partnership with the makers of Lutrish that enables CF Center Team Members and patients to make just one phone call to address nutritional needs. While increasing convenience for patients, it also shifts the administrative work involved in ordering, patient follow-up and refill management from CF Center team members to us, while enabling t...

Friday 20th April 2018

FACEBOOK SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of ...

Facebook investors should visit us at https://www.claimsfiler.com/cases/view-facebook-inc-securities-litigation-2or call to speak to our claim center toll-free at (844) 367-9658.   About the Lawsuit Facebook and Read more...

Institute to host workshop on artificial intelligence and machine learning in financial services

(Rensselaer Polytechnic Institute) The Center for Financial Studies in the Lally School of Management at Rensselaer Polytechnic Institute will host a one-day workshop titled Artificial Intelligence and Machine Learning in Financial Services. The workshop will take place on April 27 from 8 a.m. to 5 p.m. in the Center for Biotechnology and Interdisciplinary Studies Auditorium on campus.

[Comment] The complement story in Guillain-Barré syndrome: from pathogenesis to therapy

Guillain-Barré syndrome is a rapidly evolving neuropathy that often occurs after an acute infection.1 Most patients become severely disabled and unable to walk within a few days of onset, with 20–30% of them requiring assisted ventilation. Up to 10% of patients die of the disease from pneumonia or from cardiac or thromboembolic complications. Guillain-Barré syndrome is typically a monophasic d...

Tocagen Reaches Exclusive Deal in China for Brain Cancer Therapy

Roughly a year and a half after Tocagen (NASDAQ: TOCA) named Marty Duvall as CEO, the San Diego biotech said it has signed a deal that gives Beijing-based ApolloBio an exclusive license to its gene therapy treatment for a deadly type of brain cancer. Under terms of the deal, ApolloBio agreed to make a $16 […]

PT. SOHO Industri Pharmasi Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14032018] Prices from USD $250

SummaryPT. SOHO Industri Pharmasi PT SOHO, a subsidiary of PT. SOHO Global Health is a pharmaceutical company that offers ethical, consumer health, herbal medicine and natural products. The company's products include analgesic, antiinflammatory, antipyretic, antibiotics, antifungal, antihistamine and antiallergy, antihyperlipidaemic, antipsychotic, antiviral, corticosteroid, h2 blocker, proton pum...

CPRIT awards $2 million grant to push forward breast cancer research in West Texas

A $2 million grant from the Cancer Prevention and Research Institute of Texas will allow Texas Tech University Health Sciences Center El Paso to create a new lab focusing on breast cancer, pushing forward breast cancer research in West Texas.

CORRECTING and REPLACING Neurotechnology Innovations Translator (NIT) Announces Funding of up to $50 Million in Portfolio Company Sollis Therapeutics

Pioneering therapy to enter US pivotal trial for treatment of pain from sciatica Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: NEUROTECHNOLOGY INNOVATIONS TRANSLATOR (NIT) ANNOUNCES FUNDING OF UP TO $50 MILLION IN PORTFOLIO COMPANY SOLLIS THERAPEUTICS ...

Polycythemia Pipeline Insight, 2018 [Report Updated: 14022018] Prices from USD $1250

"Polycythemia Pipeline Insight, 2018 report by DelveInsight offers comprehensive Insight of the pipeline under development therapeutics scenario and growth prospects across Polycythemia development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associate...

University of Utah College of Science opens new Crocker Science Center

Housed in the historic and newly renovated George Thomas Building, the Crocker Science Center will be the new home to the Henry Eyring Center for Read more...

Medline Expands Ability to Offset Carbon Footprint with Completion of Second Solar Installation in North America

Fifth installation worldwide marked by 1.1 Megawatt system in Rialto, California Medline today announced the completion of the second in a series of solar installations being undertaken to meet the organization’s growing sustainability goals. The 1.1 Megawatt system is estimated to generate power equivalent to 75 percent of that facility’s u...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks